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UV light assisted antibiotics for 
eradication of in vitro biofilms
Aikaterini Argyraki1, Merete Markvart2, Camilla Stavnsbjerg3,4, Kasper Nørskov Kragh3, 
Yiyu Ou  1, Lars Bjørndal2, Thomas Bjarnsholt  3,4 & Paul Michael Petersen1
The overuse of antibiotics is accelerating the bacterial resistance, and therefore there is a need to 
reduce the amount of antibiotics used for treatment. Here, we demonstrate in vitro that specific 
wavelengths in a narrow range around 296 nm are able to eradicate bacteria in the biofilm state (grown 
for 24 hours) more effectively, than antibiotics and the combination of irradiation and antibiotics 
is even better, introducing a novel concept light assisted antibiotics. The investigated wavelength 
range was 249 nm to 338 nm with an approximate step of 5 nm. The novel concept that consists of a 
UV irradiation treatment followed by a tobramycin treatment can significantly reduce the amount 
of antibiotics needed for eradicating mature bacterial biofilms. The efficiency of the proposed 
light assisted antibiotics method was compared to combinatory antibiotic treatment and highly 
concentrated antibiotic monotherapy. The eradication efficacies, on mature biofilms, achieved by light 
assisted antibiotic and by the antibiotic monotherapy at approximately 10-fold higher concentration, 
were equivalent. The present achievement could motivate the development of light assisted antibiotic 
treatments for treating infections.
There is a worldwide increasing awareness and concern about the antibiotic resistance, which in the future could 
prevent effective treatment of a large number of infectious diseases1. The emergency of antibiotic resistance has 
evoked a “turn” towards antibiotics control/reduction programs2. Moreover, biofilm infections are highly per-
sistent to the immune response and known for their tolerance to antibiotic treatments3. Alternative approaches, 
different than conventional antibiotic treatments, are gaining increasing interest and light based treatments4 are 
unconventional strategies for biofilm eradication. Bak et al. has reported disinfection potential of catheter lumens 
by UVC LEDs5. Recently, we have observed that UVB irradiation is more efficient than UVC, in eradicating bio-
films plated on cellulose nitrate membrane filters6. However, the ultraviolet (UV) wavelength dependent eradica-
tion efficiency for Pseudomonas aeruginosa biofilms has not been reported. Apart from UV light, also exposure 
to blue light has been proven to have antimicrobial effect, without the requirement of exogenous photosensitizers 
present7.
UV light emitting diodes (LEDs) are progressing as light source options in biomedical applications mainly 
due to their flexibility in spectral design and ease in operation. AlGaN LEDs are continuously progressing as 
UV light sources. A wavelength as short as 210 nm has been achieved with pure AlN LEDs8. External quantum 
efficiency (EQE) of UV LEDs is continuously improving as both internal quantum efficiency (IQE) and light 
extraction efficiency (LEE) are boosted by various techniques like: migration-enhanced metalorganic chemical 
vapor deposition9,10, ammonia pulsed-flow method11,12 and nanowires13, or surface plasmons14 and aluminum 
reflective electrodes15, respectively. EQE above 10% has been reported when approaches for improving IQE and 
LEE are applied in combination16.
Combinatory therapies seem to be the solution for combating tolerant biofilms present in chronic infec-
tions17,18. Particularly, if the combinatory treatments enact complementary mode of actions then synergy can be 
expected, and therefore, better eradication efficiency19–21.
Biofilms are complex formations created by bacteria to improve their chances of survival. More specifi-
cally, biofilms can be 10 to 1000 times more tolerant than the planktonic phenotype22. The organization and 
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composition existing in a biofilm makes the treatment of biofilm infections challenging since bacteria in biofilms 
can employ specific mechanisms to tolerate bactericidal treatments. The origin of biofilm tolerance is mostly 
caused by low metabolic activity of the bacteria within the biofilm, but it also has a genetic basis23,24. Furthermore, 
the physical barrier of the biofilm matrix, limits the diffusion of molecules25 into the biofilm, and reduces anti-
microbial penetration.
Common sites of biofilm infections in the human body are the oral cavity, e.g. caries is the most frequent 
disease affecting human health26, burdening billions of individuals with pain, limited masticatory functions 
and impaired aesthetics. In particular, the deep carious lesions27, as well as its sequelae, the infected root canal 
associated with biofilm infection, represent targets for improved antimicrobial strategies and represent unsolved 
demanding challenges within the dental community28. Also within, the urinary system, the lungs of cystic fibrosis 
patients and chronic wounds biofilm infections are common. Additionally, when medical devices, like catheters, 
endoscopes, tissue fillers, implants, iatrogenic placed endodontic root filling materials, etc. are inserted into the 
body, the risk for chronic biofilm infection increases29.
There is urgent need to enable elimination of chronic biofilm infections without utilizing excessive amounts of 
antibiotics. The present study could assist in developing light assisted combinatory treatments, consisting of irra-
diation in combination with antibiotics. The scope is to achieve total biofilm eradication and reduce the amount 
of antibiotics needed for treating infections.
In the present work we aimed to demonstrate the wavelength dependent survival of 24 h (h) grown P. aerugi-
nosa biofilms in the range 249 nm to 338 nm with an approximate step of 5 nm. The photon rate was 0.0036 mol/m2; 
corresponding to a radiant exposure of 1.700–1.260 J/m2. We report remarkable eradication (eradication log 
higher than 8) for the 24 h old biofilms after irradiation in the 292–306 nm range for 0.0495 mol/m2 photon rate, 
corresponding to a radiant exposure 17.500–21.100 J/m2. A UVC treatment at that exposure level could have 
negative implications to the healthy tissue infected by the biofilm; therefore, the wavelengths tested at this higher 
level of radiant exposure were restricted only to the UVB and UVA region.
To demonstrate the antimicrobial effect of the irradiation method, we compared the irradiation strategy with 
two types of antibiotics that are well recognized for their usage against P. aeruginosa biofilm infections, namely 
tobramycin30 and colistin31 both as monotherapy. The hypothesis was no difference of the eradication efficacy of 
the three different treatments: UVB or antibiotic monotherapies, on in vitro P. aeruginosa biofilms either grown 
for 24 h or 48 h.
Light assisted antibiotic treatments for biofilm infections could be a method to improve the therapy of biofilm 
infections in the future, since light has been shown to have antibacterial action at several wavelengths7: UVC, 
UVB, UVA, blue, infrared. Here, we demonstrate the light assisted antibiotic principle in specific, by applying 
irradiation with a UV LED exhibiting central wavelength at 296 nm and by subsequently administrating topically 
tobramycin, to combat bacteria of P. aeruginosa biofilms grown for 24 h (immature) or 48 h (mature). The biofilm 
eradication of the light assisted tobramycin is compared to the effect achieved by 10-fold more concentrated 
tobramycin, as well as combinatory antibiotic treatments, consisting of tobramycin and colistin at two concentra-
tion levels. Tobramycin and colistin are known to be used in combination due to the increased effectiveness of the 
combined treatment compared to monotherapy18. The hypothesis was no difference of the eradication efficacy of 
the four different treatments: light assisted tobramycin or 10-fold more concentrated tobramycin monotherapy 
and combinatory antibiotics at two different concentration levels, on in vitro P. aeruginosa biofilms either grown 
for 24 h or 48 h.
The proposed method is relevant for combating biofilms and could assist in developing new combinatory 
therapies consisting of light application and usage of antibiotics to improve treatment of chronic biofilm infec-
tions in complex ecosystems e.g. the dental root canal system32, as well as treating postoperative infection adjacent 
to biomedical implants.
Results
Wavelength dependent survival of biofilms. The survival of the biofilms after each treatment, was cal-
culated according to Eq. 1
=





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N
eradicationlog log log
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treated
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where Ntreated is the number of colony forming units (CFUs) per micropore filter after a treatment is applied 
to the biofilm, and N control is the number of CFUs per micropore filter of non-treated samples. The wave-
length dependent survival of the P. aeruginosa biofilms grown for 24 h is presented in Fig. 1. All treatments were 
repeated on three different biological replicates.
UVA irradiations were performed with LEDs having central wavelengths from 318 nm to 338 nm, UVB irra-
diations from 281 nm to 313 nm, covering the whole UVB spectral range, and UVC irradiations from 249 nm 
to 274 nm. It was observed that the estimated CFUs of the UVA treated samples, independently of wavelength 
applied, were similar to non-treated samples (control). The log survival was 0.13 ± 0.17. Independently of wave-
length, UVC treated samples exhibited a log eradication 0.36 ± 0.15 (Eq. 1). UVB irradiated samples to the con-
trary exhibited strong dependence of wavelength and eradication ability and less CFUs were observed, especially 
for the range 292 to 300 nm. The treatment with the diode having central wavelength at 296 nm exhibited the 
strongest eradication potential on P. aeruginosa 24 h grown biofilms with log eradication 2.39 ± 0.78.
The eradication ability at a radiant UVB exposure, equivalent to 12 h of summer sunlight in Northern Europe, 
was remarkable (eradication log higher than 8) for the wavelength range 292–306 nm (Fig. 2). The observed result 
suggested that a UVB radiant exposure of that level and at this wavelength range could also enact eradication 
effects on mature biofilms that are known for their increased tolerance to antibacterial treatments.
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UVB irradiation treatment versus topically administrated antibiotics. Three treatments were 
applied on P. aeruginosa biofilms grown for 24 h or 48 h, namely UVB irradiation (sunlight equivalent, 20.000 J/m2), 
or topical administration of antibiotics; either tobramycin or colistin at one hundred times the minimal inhibitory 
concentration (MIC). Two-way analysis of variance (ANOVA) revealed that there was a significant difference in 
eradication of biofilms for the three treatments for 24 h grown biofilms. UVB, compared to colistin or tobramycin, 
was significantly better at eradicating 24 h immature biofilms with p. values of P < 0.0001 and P < 0.0001, respec-
tively. No significant difference was observed for the 48 h grown biofilm.
The biofilm eradication achieved by the three different treatments is presented in Fig. 3. The eradication 
achieved by the UVB irradiation treatment was lower on mature biofilms (1.11 ± 0.13 log eradication) than on 
immature biofilms (6.31 ± 1.58 log eradication). However, the UVB treatment was more efficient in eradicat-
ing biofilms than the antibiotics. The colistin treatment resulted in negligible eradication, independently of the 
Figure 1. Wavelength dependent survival of P. aeruginosa biofilm grown for 24 h. The photon rate delivered on 
the biofilms by the UV LEDs was 0.0036 mol/m2, corresponding to a radiant exposure 1.260 J/m2 to 1.700 J/m2, 
respectively, for the wavelengths 338 nm to 249 nm. Three biological replicates were generated for all treatments.
Figure 2. Survival of biofilm after UVB or UVA LED exposure, the level of exposure was equivalent to what can 
be received by sunlight. The photon rate delivered on the biofilms by the UVB and UVA LEDs was 0.0495 mol/m2,  
corresponding to a radiant exposure 17.500 J/m2 to 21.100 J/m2. The biofilms were P. aeruginosa and grown for 
24 h. The peculiar observation indicated by the black arrow led us to perform several repetitions of this specific 
treatment; all repetitions resulted in log eradication higher than 8. The dashed box comprises measurements 
corresponding to zero counts. The measurements in the dashed box in Fig. 2 correspond to zero counts, i.e. 
complete eradication of the biofilm.
www.nature.com/scientificreports/
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biofilm growth. The tobramycin treatment enacted a moderate eradication on immature biofilms (1.34 ± 0.08 log 
eradication), but only negligible eradication on mature biofilms.
Light assisted antibiotics. The CFU/filter values of the different treatments on 24 h and 48 h grown bio-
films are presented in Table 1 together with the ones of untreated reference samples. The measurements include 
UVB, colistin (100MIC), tobramycin (100MIC), tobramycin (1000MIC), tobramycin (100MIC) + colistin 
(100MIC), tobramycin (1000MIC) + colistin (300MIC), UVB + tobramycin (100MIC). All treatments were 
repeated on three different biological replicates. For each biological replica, two technical replicas were applied 
and the average CFU/filter value of the two replicas was taken and shown in Table 1.
The biofilm eradication achieved by the suggested method of light assisted antibiotics on mature samples is 
presented in Fig. 4. The eradication achieved by combinatory administration of antibiotics, and after adminis-
tration of highly concentrated monotherapy is also shown in Fig. 4. The one-way ANOVA analysis showed that 
there was a significant difference (p-value 0.0003) in the eradication achieved by the light-assisted treatment 
UVB + tobramycin (100MIC) shown in Fig. 4 and the treatment tobramycin (100MIC) shown in Fig. 3 for 48 h 
grown biofilms.
The light assisted tobramycin was even more effective than the combinatory antibiotics tobramycin and colis-
tin (low-level concentration); and for 48 h biofilms the method of light assisted antibiotics was approximately 
equally as effective as 10 times higher concentration of tobramycin. Interestingly, the light assisted tobramycin 
treatment approached the eradication values achieved by topical administration of combinatory antibiotics at 
high concentrations.
Discussion
In vivo and in vitro experiments have previously validated that the tolerance for biofilms are usually considerably 
higher (approx. 10–1000 times) than the planktonic bacterial cells33. Therefore, eradication of biofilms by con-
ventional antibiotic administration can be challenging due to potential side effects or accumulated toxicity34. The 
demand for discovering alternative methods to eradicate biofilms, which may be involved in chronic infections, 
has been identified for a long time. Moreover, the need to develop treatments that would increase the vulnerability 
of biofilms to well-recognized therapeutic methods (e.g. antibiotics) has been acknowledged35. The established 
root canal infection associated with an apical periodontitis (i.e. inflammation surrounding the apical portion of 
the dental root) provides an area where light assisted antibiotics is applicable, as the prevailing combination of 
instrumentation and use of medicaments (e.g. sodium hypochlorite) do not completely sterilize the root canal 
system36. The concept of irrigation with MTAD (antibiotic solution) might be improved in combination with UV 
irradiation37. In addition, postoperative infections adjacent to biomedical dental implants remain a significant 
problem, which can lead to early implant failure38. The use of systemic antibiotics does not exert a significant 
preventive effect against these postoperative infections39. Thus, a final definition is still lacking of which drugs and 
administration regimens are the most effective antibiotic treatment protocol. The concept presented in this paper 
represents an option that could be used for treating established implant infections.
Several bacterial species have previously been studied for their sensitivity towards UV irradiation, like 
Escherichia coli40, and the optimal germicidal wavelength was found to lie within the UVC range with a maximum 
around 270 nm. However, the germicidal efficiency was studied for bacteria in the planktonic state. Bacteria in 
Figure 3. Eradication of biofilms after UVB irradiation treatment (sunlight equivalent), or topical 
administration of antibiotics; colistin or tobramycin at hundred times the MIC. The biofilms were either left to 
grow for 24 h before treatment or for 48 h. The error bars indicate the standard deviation as acquired by three 
biological replicates. “MIC” stands for minimal inhibitory concentration.
www.nature.com/scientificreports/
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the planktonic state exist as individuals, while biofilms are aggregated bacteria. The peak of absorption of bacte-
rial genetic material is located a few nanometers lower around 260–265 nm41, and this supported the hypothesis 
that direct UVC absorption by bacterial genetic material, inhibits normal replication, and results in bacterial 
eradication42–45.
In the present study it was shown that the eradication efficiency of UV irradiation on 24 h grown P. aerugi-
nosa biofilms is wavelength dependent, and that the optimum region is located in the UVB range around 296 nm 
(292–300 nm). The maximum optical thickness for the 24 h grown P. aeruginosa biofilms treated in the present 
work was 75 ± 17 µm and for the 48 h grown 104 ± 12 µm. The maximum physical thickness was respectively 
100 ± 23 µm and 138 ± 16 µm for the 24 and 48 h grown biofilms.
In the biofilm state, the smaller penetration achieved by shorter wavelengths is expected to reduce the eradica-
tion efficacy of UVC6. In the UVA region and longer wavelengths bacterial eradication is dictated only by indirect 
pathways like generation of reactive oxygen species, and therefore, the eradication efficiency is much lower46. 
UVB is located spectrally between the UVC and UVA regions; and involves elements from both indirect and 
direct bacterial impairment47,48. Studies on UVB lethality and mutagenesis of bacterial suspensions have shown 
that lethality occurs at a few nanometers longer wavelengths than mutagenesis49. Photons with UVB wavelengths 
in the 292–307 nm interval are expected to bring enough energy to break bonds like C-H and N-H50, essential 
for the tertiary structure of proteins and DNA51. In the human skin, free radical generation exhibits high effi-
ciency for wavelengths around 303 nm (UVB range) and 355 nm (UVA range)52. Recently, a product with strong 
Treatment
Biofilms
1treat 1ref 2treat 2ref 3treat 3ref
24 hours 48 hours 24 hours 48 hours 24 hours 48 hours 24 hours 48 hours 24 hours 48 hours 24 hours 48 hours
UVB 1,67E + 02 2,59E + 08 1,85E + 09 4,25E + 09 8,31E + 04 3,14E + 08 2,64E + 09 4,47E + 09 1,50E + 02 4,87E + 08 3,65E + 09 4,49E + 09
colistin(100MIC) 1,16E + 09 2,73E + 09 2,14E + 09 4,63E + 09 1,97E + 09 3,41E + 09 4,29E + 09 4,75E + 09 1,73E + 09 3,18E + 09 4,07E + 09 4,85E + 09
tobramycin(100MIC) 1,08E + 08 3,40E + 09 2,14E + 09 4,63E + 09 1,57E + 08 3,32E + 09 4,29E + 09 4,75E + 09 2,03E + 08 3,69E + 09 4,07E + 09 4,85E + 09
tobramycin(1000MIC) 1,15E + 07 6,21E + 06 8,33E + 09 8,64E + 09 6,50E + 06 1,53E + 07 4,82E + 09 1,05E + 10 8,00E + 06 1,15E + 07 6,97E + 09 8,18E + 09
tobramycin(100MIC) 
+ colistin(100MIC) 3,09E + 06 1,58E + 09 2,14E + 09 4,63E + 09 9,31E + 06 1,09E + 09 4,29E + 09 4,75E + 09 2,84E + 06 1,27E + 09 4,07E + 09 4,85E + 09
tobramycin(1000MIC) 
+ colistin(300MIC) 0,00E + 00 3,94E + 05 8,33E + 09 8,64E + 09 0,00E + 00 3,05E + 05 4,82E + 09 1,05E + 10 0,00E + 00 3,24E + 05 6,97E + 09 8,18E + 09
UVB + 
tobramycin(100MIC) 0,00E + 00 1,35E + 07 1,85E + 09 4,25E + 09 0,00E + 00 2,36E + 07 2,64E + 09 4,47E + 09 2,70E + 03 1,96E + 06 3,65E + 09 4,49E + 09
Table 1. CFU/filter values of P. aeruginosa biofilms after different treatments and the ones of untreated 
reference samples. P. aeruginosa biofilms grown by 24 h and 48 h were investigated. ‘24 hours’ and ‘48 hours’ 
refer to the biofilm state; ‘1’, ‘2’, ‘3’ refer to the biological replicates; ‘treat’ refers to the CFU/filter value after 
irradiations; and ‘ref ’ refers to the CFU/filter value without treatment, as reference sample.
Figure 4. Eradication of biofilms achieved by light assisted tobramycin versus topical administration of 10-
fold more concentrated tobramycin or combinatory antibiotics at two concentration levels. The biofilms were 
grown for 48 h before treatment. The error bars indicate the standard deviation as acquired by three biological 
replicates. “MIC” stands for minimal inhibitory concentration.
www.nature.com/scientificreports/
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absorbance at 297 nm was reported by Puri et al.53 as present in Methylobacter tundripaludum supernatants in a 
quorum sensing dependent manner. The collected product was reported to have no distinguishable growth inhib-
itory activity against E. coli MG 1655 or Bacillus subtilis PY79, however, a possible growth inhibitory action of the 
product was not excluded for other bacterial species.
The route of antibiotic administration in the present study was that antibiotics were added directly to the 
biofilm. Therefore, the biofilm should be directly accessible to the antibiotic administration. The level of biofilm 
tolerance towards UV radiation or antibiotics may depend on how the biofilm has been cultured and which 
model was used. In the present work, it was demonstrated that when tobramycin at a concentration, which only 
imposed negligible eradication effect on 48 h grown biofilms, was administrated after UVB irradiation; it caused 
much larger eradication efficacy (2.71 ± 0.57 log eradication) and reached the same eradication values as 10-fold 
more concentrated tobramycin. The eradication effect from UVB alone on 48 h grown biofilms was significantly 
lower (1.11 ± 0.13 log eradication). This indicates a synergetic effect of light and antibiotics of which the exact 
mechanism remains to be understood and optimized according to the taxonomic diversity of the biofilm to be 
eradicated. The improved synergy for 48 h grown biofilms is interesting since the 48 h grown biofilm have fully 
developed antibiotic tolerance. It seems that the method of light assisted antibiotics is very suited for eradication 
of bacteria in mature biofilms with a fully developed tolerance.
Conclusion
In conclusion, we have tested the efficiency of UV irradiation treatments to eradicate P. aeruginosa biofilms 
grown for 24 h in the wavelength range 249 nm to 338 nm with an approximate step of 5 nm. It was shown that 
the log survival of the biofilm was remarkably reduced for the wavelength range 292–306 nm, and the optimum 
was located at 296 nm. Moreover, we demonstrated that the UVB irradiation was more efficient than topical 
administration of antibiotics (colistin or tobramycin at 100 MIC) for eradicating biofilms grown for 24 h or 48 h.
A novel method was introduced, light assisted antibiotics, for eradicating mature biofilms and successfully 
reducing the amount of antibiotics used for disinfection. A specific light assisted antibiotic example was pre-
sented; namely, irradiation with a UV LED exhibiting central wavelength at 296 nm combined with topical 
administration of tobramycin at 100 MIC. This treatment reduced the bacterial load on 48 h grown biofilms 
by approximately 3 logs, equivalent to the effect as that achieved by administrating 10-fold more concentrated 
tobramycin (1000 MIC). The eradication achieved by the treatment was observed to be more effective than com-
binatory antibiotic treatment, 100 MIC of colistin plus 100 MIC of tobramycin. The present study can assist in 
developing new combinatory treatments consisting of light and usage of antibiotics to improve treatments of 
chronic biofilm infections within chronic wounds or within the infected root canal system treating infections in 
the jaw.
Methods
Biofilm preparation. The bacterial strain used in the experiments was P. aeruginosa PAO1 obtained from 
the Pseudomonas Genetic Stock Center (strain PAO0001, www.pseudomonas.med.ecu.edu)54. The micropore 
assay methodology used to form the biofilms was based on Bjarnsholt et al.55, in brief: The Micro-pore assay is 
based on biofilms growing on a micropore filter on AB minimal medium supplemented with glucose and mixed 
with 2.0% agar (AGBT) (Substrate Department at the Panum Institute, Denmark). The Cellulose nitrate mem-
brane filters with pore size 0.2μm and diameter 25 mm purchased from Whatman GmbH (Germany) were placed 
on top of the ABGT plate. Bacteria from overnight cultures are propagated on the micro-pore filters as spots of 
20 µl bacterial suspensions and incubated at 37 °C. For a mature biofilm to develop the filters were transferred 
to a fresh AB minimal agar plate after 24 h. Treatments were applied to the biofilms after either 24 h (immature 
biofilm) or 48 h (mature biofilm) incubation in total, at 37 °C56. It is observed that the control biofilms have a 
bacterial density in a level of 109–1010 CFU/filter.
Biofilm thickness measurement. Maximum biofilm thickness was measured by staining filter biofilms 
with 10 µl (2.5 μM) of universal fluorescent nucleotide stain Syto9 (Invitrogen, USA). Biofilms were imaged as 
a line-box, measuring 10171 µm (X) × 60.25 µm (Y) x 294 µm (Z) with 5 µm increments in the Z direction on 
confocal microscope (Zeiss Imager.Z2 microscope with LSM 710 CLSM running Zeiss Zen 2010 v. 6.0. (Zeiss, 
Germany)). A 488 nm laser was used for excitation and a 505–525 nm filter with a peak a 509 nm for emission. 
These settings provided a profile image as a cross-section from edge to edge of the filter biofilm. With the use of 
Imaris 9.0 (Bitplane, Schweiz) thickness of the biofilm was measured. In the format “section view” the profile of 
the biofilm could be measured as the length from the top point to the base of on the filter membranes surface. The 
biofilms were measured at the highest point at the edge, approx. 300 µm from edge on each side of the biofilm; 
additionally, the center of the biofilm was measured as well.
UV Irradiations. The UV LEDs that were used to perform the irradiation treatments were purchased from 
Sensor Electronic Technology, Inc (SETi, Columbia, SC, USA). The spectral irradiance of the diodes used to 
determine the optimal biofilm eradication wavelength, is depicted in Fig. 5. The spectral irradiance was measured 
by an External Optical probe (EOP-146, Instrument Systems GmbH, Munich, Germany) and a monochromator. 
The spectrometer used was a SPECTRO 320 (D) Release 5 (Instrument Systems GmbH). The exact protocol for 
measuring the spectral irradiance can be found in Barnkob et al.57. The irradiance delivered on the biofilms was 
measured with a portable radiometer (NIST Certified UV Radiometer) at a distance (1.5 ± 0.1 cm). The distance 
between the biofilms and the UV LEDs was 1.5 ± 0.2 cm for all exposures; the error originates from the agar 
height, on which the filter carrying the biofilm was placed. The biofilms were kept in a UV free environment, 
when not treated. The UV treatment was conducted at a temperature of 20 °C for all the samples.
www.nature.com/scientificreports/
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Antibiotic treatments. The antibiotics used in this study were tobramycin (Eurocept International, 
Netherlands) and colistin sulfate salt (Sigma-Aldrich, USA). The MIC concentration for colistin was determined 
as 0.8 µg/mL and for tobramycin 1 µg/mL. The antibiotic treatments delivered were: 100 µg/mL tobramycin 
(100 MIC); 80 µg/mL colistin sulfate salt (100 MIC); tobramycin and colistin high (tobramycin + colistin high): 
1000 µg/mL tobramycin (1000 MIC) and 250 µg/mL colistin sulfate salt (~300 MIC); tobramycin and colistin low 
(tobramycin + colistin low): 100 µg/mL tobramycin and 80 µg/mL colistin sulfate salt; 1000 µg/mL tobramycin 
(1000 MIC). For the light assisted antibiotic treatment; 100 µg/mL tobramycin were delivered after UVB was 
applied (sunlight equivalent, 20.000 J/m2). The antibiotics were added into the ABTG agar plates and biofilms 
were treated by moving the biofilm growing on nitrocellulose filters to the antibiotic containing media plates.
CFU determination. The method for quantitative bacteriology is described in Argyraki et al.6; and distinct 
samples were used for the CFU determination. Following treatment the filter biofilm was transferred with ster-
ile forceps to 5 mL saline (0.9% NaCl) and detached through sonication in an Branson B2510-DTH ultrasonic 
cleaner (5 min degas followed by 5 min sonication). Serial dilutions in the cases of UVB irradiation treatment ver-
sus topically administrated antibiotics and light assisted antibiotics were performed from 100 (no dilution) to 10−7 
and the spotted volume was 10 μL performed in triplicate; resulting in a detection limit of 100 bacteria per ml.
Statistics. All treatments were performed on three different biological replicates (n = 3), based on two or 
three technical replicates, as a standard for testing reproducibility. The statistical dispersion was measured as 
standard deviation, reported in errors, and is of biological origin if not stated otherwise in the text. One-way 
ANOVA or two-way ANOVA followed by Bonferoni corrected multiple comparison were performed in GraphPad 
Prism 7.01.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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